insitro

insitro is a biotech company founded in 2018 by Daphne Koller, focusing on transforming drug discovery through machine learning and large-scale biological data. The company aims to improve the traditional drug development process by using artificial intelligence to accelerate the discovery of new therapeutics for various diseases. The core of insitro's work is its machine learning-driven platform, which integrates in vitro cellular data with human clinical data. This platform is designed to enhance the understanding of diseases and identify therapeutic insights, ultimately speeding up the development of innovative therapies. The company collaborates with leading pharmaceutical firms and academic institutions to access valuable datasets, further enhancing its drug discovery capabilities. insitro's interdisciplinary team includes life scientists, data scientists, engineers, and drug hunters, all working together to design experiments, build models, and analyze results. The company's vision is to deliver better drugs more quickly to patients, contributing to advancements in personalized medicine.